Arrhythmogenic right ventricular cardiomyopathy.
Arrhythmogenic right ventricular cardiomyopathy is a cardiac disorder manifested by the replacement of the ventricular myocardium by fibro fatty tissue and has been known to cause sudden cardiac death in young adults. In 30% to 50% of cases, the disease has familial links, which can have implications for the patients and families involved. Achieving a diagnosis can be taxing on all involved, and for the patient, it can mean having to go through a battery of tests. Once diagnosis has been confirmed, treatment for the disease includes implantation of an implantable defibrillator and/or pharmacotherapy to control the ventricular tachyarrhythmias.
Pike
Rodolfo
R
Cardiac/Critical Care Program, Health Science Centre, St. John's, NL. Rodolfo.pike@easternhealth.ca
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D019571:Arrhythmogenic Right Ventricular Dysplasia / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D017115:Catheter Ablation; D016757:Death, Sudden, Cardiac / Q000209:etiology; D017147:Defibrillators, Implantable; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D015994:Incidence; D008403:Mass Screening; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D055815:Young Adult
D000889:Anti-Arrhythmia Agents